Cardiovascular diseases are the first worldwide causes of death, associated to the presence and rupture of atherosclerotic plaques. To limit acute events, statins may be prescribed. However, its use leads to deleterious effects risk. To reduce this risk, a dose reduction could be considered. The work of this thesis is to study potential effects of a very low dose of atorvastatin, taken in the long term, in an animal model: the Watanabe rabbit. Measurements are made on control and treated animals from the age of 3 to 12 months. Circulating lipids, biochemical parameters and parameters of adhesion and inflammation were studied. Atherosclerosis evolution was evaluated by optical coherence tomography (OCT). Histological measurements allowed to ...
AbstractBackgroundTo examine the effects of pitavastatin on atherosclerotic plaque in Watanabe herit...
The in vivo activity of different 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibito...
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) contributes to atherosclerotic plaque instabil...
Cardiovascular diseases are the first worldwide causes of death, associated to the presence and rupt...
Les maladies cardiovasculaires sont la première cause de mortalité dans le monde, en lien notamment ...
PubMed ID: 21731885Background: The aim of this study was to determine the oxidant-antioxidant status...
OBJETIVO: Comparar os efeitos da atorvastatina, fluvastatina, pravastatina e simvastatina sobre a fu...
The aim of this study is to verify the evolution and involution of experimental atherosclerosis in r...
L'athérosclérose est une maladie cardiovasculaire qui se développe avec l'âge et qui est caractérisé...
Oxidized Low-Density Lipoproteins (oxLDL) and autoantibodies against oxLDL are important in the dev...
In this study, blood samples of rabbits were collected to measure plasma total cholesterol, total tr...
Oxidized Low-Density Lipoproteins (oxLDL) and autoantibodies against oxLDL are important in the deve...
Atherosclerosis is a cardiovascular disease developing with ageing characterized by lipid deposition...
As nanopartículas lipídicas (LDE) demonstraram eficácia como veículo de direcionamento de fármacos n...
WOS: 000303254500001PubMed ID: 225479923-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inh...
AbstractBackgroundTo examine the effects of pitavastatin on atherosclerotic plaque in Watanabe herit...
The in vivo activity of different 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibito...
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) contributes to atherosclerotic plaque instabil...
Cardiovascular diseases are the first worldwide causes of death, associated to the presence and rupt...
Les maladies cardiovasculaires sont la première cause de mortalité dans le monde, en lien notamment ...
PubMed ID: 21731885Background: The aim of this study was to determine the oxidant-antioxidant status...
OBJETIVO: Comparar os efeitos da atorvastatina, fluvastatina, pravastatina e simvastatina sobre a fu...
The aim of this study is to verify the evolution and involution of experimental atherosclerosis in r...
L'athérosclérose est une maladie cardiovasculaire qui se développe avec l'âge et qui est caractérisé...
Oxidized Low-Density Lipoproteins (oxLDL) and autoantibodies against oxLDL are important in the dev...
In this study, blood samples of rabbits were collected to measure plasma total cholesterol, total tr...
Oxidized Low-Density Lipoproteins (oxLDL) and autoantibodies against oxLDL are important in the deve...
Atherosclerosis is a cardiovascular disease developing with ageing characterized by lipid deposition...
As nanopartículas lipídicas (LDE) demonstraram eficácia como veículo de direcionamento de fármacos n...
WOS: 000303254500001PubMed ID: 225479923-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inh...
AbstractBackgroundTo examine the effects of pitavastatin on atherosclerotic plaque in Watanabe herit...
The in vivo activity of different 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibito...
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) contributes to atherosclerotic plaque instabil...